<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35215212</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-0817</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Pathogens (Basel, Switzerland)</Title><ISOAbbreviation>Pathogens</ISOAbbreviation></Journal><ArticleTitle>Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">269</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/pathogens11020269</ELocationID><Abstract><AbstractText>Emerging evidence has shown that COVID-19 survivors could suffer from persistent symptoms. However, it remains unclear whether these symptoms persist over the longer term. This study aimed to systematically synthesise evidence on post-COVID symptoms persisting for at least 12 months. We searched PubMed and Embase for papers reporting at least one-year follow-up results of COVID-19 survivors published by 6 November 2021. Random-effects meta-analyses were conducted to estimate pooled prevalence of specific post-COVID symptoms. Eighteen papers that reported one-year follow-up data from 8591 COVID-19 survivors were included. Fatigue/weakness (28%, 95% CI: 18-39), dyspnoea (18%, 95% CI: 13-24), arthromyalgia (26%, 95% CI: 8-44), depression (23%, 95% CI: 12-34), anxiety (22%, 95% CI: 15-29), memory loss (19%, 95% CI: 7-31), concentration difficulties (18%, 95% CI: 2-35), and insomnia (12%, 95% CI: 7-17) were the most prevalent symptoms at one-year follow-up. Existing evidence suggested that female patients and those with more severe initial illness were more likely to suffer from the sequelae after one year. This study demonstrated that a sizeable proportion of COVID-19 survivors still experience residual symptoms involving various body systems one year later. There is an urgent need for elucidating the pathophysiologic mechanisms and developing and testing targeted interventions for long-COVID patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Social Policy and Intervention, University of Oxford, Oxford OX1 2ER, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Bang</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-1814-6692</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Non-Communicable Disease Epidemiology, London School of Hygiene &amp; Tropical Medicine, London WC1E 7HT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, London W6 8RP, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daines</LastName><ForeName>Luke</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0564-4000</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Aziz</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh EH16 4UX, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_19004</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V027859/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pathogens</MedlineTA><NlmUniqueID>101596317</NlmUniqueID><ISSNLinking>2076-0817</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword><Keyword MajorTopicYN="N">symptom</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35215212</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pii">pathogens11020269</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  World Health Organization (WHO) Coronavirus (COVID-19) Dashboard.  [(accessed on 17 January 2022)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.  [(accessed on 17 January 2022)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C., Palacios-Cena D., Gomez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Intern. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Munn Z., Moola S., Lisy K., Riitano D., Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int. J. Evid. Based Healthc. 2015;13:147&#x2013;153. doi: 10.1097/XEB.0000000000000054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/XEB.0000000000000054</ArticleId><ArticleId IdType="pubmed">26317388</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyaga V.N., Arbyn M., Aerts M. Metaprop: A Stata command to perform meta-analysis of binomial data. Arch. Public Health. 2014;72:39. doi: 10.1186/2049-3258-72-39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2049-3258-72-39</ArticleId><ArticleId IdType="pmc">PMC4373114</ArticleId><ArticleId IdType="pubmed">25810908</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Hummel T., Hopkins C., Dibattista M., Menini A., Spinato G., Fabbris C., Emanuelli E., D&#x2019;Alessandro A., Marzolino R., et al. High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: A matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation. Rhinology. 2021;59:517&#x2013;527. doi: 10.4193/Rhin21.249.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin21.249</ArticleId><ArticleId IdType="pubmed">34553706</ArticleId></ArticleIdList></Reference><Reference><Citation>Aabenhus R., Thorsen H., Siersma V., Brodersen J. The development and validation of a multidimensional sum-scaling questionnaire to measure patient-reported outcomes in acute respiratory tract infections in primary care: The acute respiratory tract infection questionnaire. Value Health. 2013;16:987&#x2013;992. doi: 10.1016/j.jval.2013.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2013.06.011</ArticleId><ArticleId IdType="pubmed">24041348</ArticleId></ArticleIdList></Reference><Reference><Citation>Topp C.W., Ostergaard S.D., Sondergaard S., Bech P. The WHO-5 Well-Being Index: A systematic review of the literature. Psychother. Psychosom. 2015;84:167&#x2013;176. doi: 10.1159/000376585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000376585</ArticleId><ArticleId IdType="pubmed">25831962</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler D.A., Wells C.K. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580&#x2013;586. doi: 10.1378/chest.93.3.580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.93.3.580</ArticleId><ArticleId IdType="pubmed">3342669</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp L.B., LaRocca N.G., Muir-Nash J., Steinberg A.D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol. 1989;46:1121&#x2013;1123. doi: 10.1001/archneur.1989.00520460115022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1989.00520460115022</ArticleId><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., Cummings J.L., Chertkow H. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53:695&#x2013;699. doi: 10.1111/j.1532-5415.2005.53221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta. Psychiatr. Scand. 1983;67:361&#x2013;370. doi: 10.1111/j.1600-0447.1983.tb09716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1959;32:50&#x2013;55. doi: 10.1111/j.2044-8341.1959.tb00467.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8341.1959.tb00467.x</ArticleId><ArticleId IdType="pubmed">13638508</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56&#x2013;62. doi: 10.1136/jnnp.23.1.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.23.1.56</ArticleId><ArticleId IdType="pmc">PMC495331</ArticleId><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Blevins C.A., Weathers F.W., Davis M.T., Witte T.K., Domino J.L. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation. J. Trauma. Stress. 2015;28:489&#x2013;498. doi: 10.1002/jts.22059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jts.22059</ArticleId><ArticleId IdType="pubmed">26606250</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastien C.H., Vallieres A., Morin C.M. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2:297&#x2013;307. doi: 10.1016/S1389-9457(00)00065-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1389-9457(00)00065-4</ArticleId><ArticleId IdType="pubmed">11438246</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Guida F., Marcuzzo A.V., D&#x2019;Alessandro A., Zanelli E., Marzolino R., Lazzarin C., Antonucci P., Sacchet E., Tofanelli M., et al. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19) Int. Forum Allergy Rhinol. 2021;59:517&#x2013;527. doi: 10.1002/alr.22832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22832</ArticleId><ArticleId IdType="pmc">PMC9291310</ArticleId><ArticleId IdType="pubmed">34109765</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalan I.P., Marti C.R., Sota D.P., Alvarez A.C., Gimeno M.J.E., Juana S.F., Rodriguez G.H., Bajo E.D., Gaya N.T., Blasco J.U., et al. Corticosteroids for COVID-19 symptoms and quality of life at 1 year from admission. J. Med. Virol. 2022;94:205&#x2013;210. doi: 10.1002/jmv.27296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27296</ArticleId><ArticleId IdType="pmc">PMC8662039</ArticleId><ArticleId IdType="pubmed">34436783</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai C., Feng X., Lu M., Li S., Chen K., Wang H., Wang W., Tang Z., Cheng G., Wu X., et al. One-year mortality and consequences of COVID-19 in cancer patients: A cohort study. IUBMB Life. 2021;73:1244&#x2013;1256. doi: 10.1002/iub.2536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.2536</ArticleId><ArticleId IdType="pmc">PMC8426703</ArticleId><ArticleId IdType="pubmed">34318585</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Guijarro C., Plaza-Canteli S., Hern&#xe1;ndez-Barrera V., Torres-Macho J. Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study. Lung. 2021;199:249&#x2013;253. doi: 10.1007/s00408-021-00450-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00450-w</ArticleId><ArticleId IdType="pmc">PMC8124095</ArticleId><ArticleId IdType="pubmed">33993321</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamberini L., Mazzoli C.A., Gordini G., Prediletto I., Sintonen H., Scaramuzzo G., Volta C.A., Spadaro S., Allegri D., Colombo D., et al. Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study. Respir. Med. 2021;189:106665. doi: 10.1016/j.rmed.2021.106665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106665</ArticleId><ArticleId IdType="pmc">PMC8531241</ArticleId><ArticleId IdType="pubmed">34717097</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., Hu P., Guo L., Liu M., Xu J., et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021;398:747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Latronico N., Peli E., Calza S., Rodella F., Novelli M.P., Cella A., Marshall J., Needham D.M., Rasulo F.A., Piva S. Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS. Thorax. 2022;77:300&#x2013;303. doi: 10.1136/thoraxjnl-2021-218064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-218064</ArticleId><ArticleId IdType="pubmed">34588274</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Wu D., Yan W., Wang X., Zhang X., Ma K., Chen H., Zeng Z., Wang H., Xing M., et al. Twelve-month systemic consequences of COVID-19 in patients discharged from hospital: A prospective cohort study in Wuhan, China. Clin. Infect. Dis. 2021:ciab703. doi: 10.1093/cid/ciab703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab703</ArticleId><ArticleId IdType="pmc">PMC9187317</ArticleId><ArticleId IdType="pubmed">34390330</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Muniz M.M., Mata-Vazquez E., Martin-Toledano M., Lopez-Larramona G., Ruiz-Chicote A.M., Nieto-Sandoval B., Arias A., Lucendo A.J. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J. Clin. Med. 2021;10:2945. doi: 10.3390/jcm10132945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132945</ArticleId><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestrini V., Birtolo L.I., Francone M., Galardo G., Galea N., Severino P., Alessandri F., Colaiacomo M.C., Cundari G., Chimenti C., et al. Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up. Int. J. Cardiol. 2021;339:235&#x2013;242. doi: 10.1016/j.ijcard.2021.06.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2021.06.056</ArticleId><ArticleId IdType="pmc">PMC8253670</ArticleId><ArticleId IdType="pubmed">34224766</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez R., Balanza-Martinez V., Luperdi S.C., Estrada I., Latorre A., Gonzalez-Jimenez P., Bouzas L., Yepez K., Ferrando A., Reyes S., et al. Long-term neuropsychiatric outcomes in COVID-19 survivors: A 1-year longitudinal study. J. Intern. Med. 2022;291:247&#x2013;251. doi: 10.1111/joim.13389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13389</ArticleId><ArticleId IdType="pmc">PMC8662064</ArticleId><ArticleId IdType="pubmed">34569681</ArticleId></ArticleIdList></Reference><Reference><Citation>Rank A., Tzortzini A., Schmid C., Claus R., Kling E., Loll E., Hoffmann R., Dennehy K.M., Burger R., Grutzner S., et al. One year after mild covid-19: The majority of patients maintain specific immunity, but one in four still suffer from long-term symptoms. J. Clin. Med. 2021;10:3305. doi: 10.3390/jcm10153305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10153305</ArticleId><ArticleId IdType="pmc">PMC8347559</ArticleId><ArticleId IdType="pubmed">34362088</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J., Hippchen T., Lim A., Merle U., Waterboer T., Simon J., Kirchner M., Muller B. Persistent symptoms in adult patients one year after COVID-19: A prospective cohort study. Clin. Infect. Dis. 2021:ciab611. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Liu X., Zhou Y., Yu H., Li R., Zhan Q., Ni F., Fang S., Lu Y., Ding X., et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study. Lancet Respir. Med. 2021;9:747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y., Zhu Y., Wang S., Jia S., Gao Y., Lu Y., Zhou C., Liang R., Sun D., Wang X., et al. SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection. Signal Transduct. Target. Ther. 2021;6:368. doi: 10.1038/s41392-021-00777-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00777-z</ArticleId><ArticleId IdType="pmc">PMC8512652</ArticleId><ArticleId IdType="pubmed">34645784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Wang F., Shen Y., Zhang X., Cen Y., Wang B., Zhao S., Zhou Y., Hu B., Wang M., et al. Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China. JAMA Netw. Open. 2021;4:e2127403. doi: 10.1001/jamanetworkopen.2021.27403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27403</ArticleId><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Yang C., An X., Xiong Y., Huang L., Jia J., Xu Q., Zhang L., Zhao J., Xu A., et al. Follow-up study on COVID-19 survivors one year after discharge from hospital. Int. J. Infect. Dis. 2021;112:173&#x2013;182. doi: 10.1016/j.ijid.2021.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.017</ArticleId><ArticleId IdType="pmc">PMC8434916</ArticleId><ArticleId IdType="pubmed">34520845</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  Symptoms of COVID-19.  [(accessed on 17 January 2022)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.</Citation></Reference><Reference><Citation>Yusuf F., Fahriani M., Mamada S.S., Frediansyah A., Abubakar A., Maghfirah D., Fajar J.K., Maliga H.A., Ilmawan M., Emran T.B., et al. Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis. F1000Res. 2021;10:301. doi: 10.12688/f1000research.52216.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.52216.1</ArticleId><ArticleId IdType="pmc">PMC8171196</ArticleId><ArticleId IdType="pubmed">34131481</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E., van Willigen H.D.G., Dijkstra M., Boyd A., Kootstra N.A., van den Aardweg J.G., van Gils M.J., Matser A., de Wit M.R., Leenstra T., et al. Evolution of COVID-19 symptoms during the first 12 months after illness onset. Clin. Infect. Dis. 2021:ciab759. doi: 10.1093/cid/ciab759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab759</ArticleId><ArticleId IdType="pmc">PMC8522402</ArticleId><ArticleId IdType="pubmed">34473245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>